International Mentored Scientist Award

Spring 2024 funding cycle: Applications closed, funding results available before end of May 2024

Fall 2024 funding cycle:

  • Call opens: Thursday, August 29, 2024
  • Deadline: Monday September 30, 2024 (2:00 pm PST)
  • Funding Results: available before end of December, 2024

Amount available: $30,000 in direct costs for 1 year

Apply through the UCSF Resource Allocation Program (RAP) portal

The International Mentored Scientist Award seeks to provide a mentored career development opportunity in HIV research for international investigators affiliated with UCSF. Applicants for this award must indicate a UCSF-affiliated faculty research mentor(s) in HIV who will commit to guiding the applicant for the application process and throughout the duration of the proposed project. Project proposals should be geared toward the interests of the applicant (e.g., clinical, basic, implementation science and/or behavioral-epidemiological research) and focus on HIV research in the investigator’s home country.

Eligibility
Researchers (all levels), post-doctoral fellows, and trainees located at a UCSF-affiliated foreign institution who have not received an NIH R01- equivalent grant in HIV/AIDS are eligible. Please note that CFAR is not allowed to provide funding to any investigators who have received HIV-related R01 awards. More senior faculty members may apply only if they are newly entering the field of HIV research.

Designation of Mentor (Critical)

Mentoring is critical to the training component of the CFAR International Mentored Scientist awards. All International Mentored award applications require a faculty research mentor from UCSF or a UCSF-affiliated institution (https://cfar.ucsf.edu/about/partners). Applications without a mentor will be disqualified.

Applicants must identify their UCSF-affiliated mentors and arrange to receive mentor advice and guidance on the research portion of their application well before it is submitted (typically at least two months before the RAP deadline). CFAR is no longer available to assist with mentor identification.

Projects must be within NIH’s HIV/AIDS research high or medium priority areas. Projects in closely related areas (e.g. TB, HCV, drug use, etc.) must be clearly linked to HIV in order to be eligible for CFAR funding.

The award amount is $30,000 in direct costs for one year.
For more detailed information about this RFA, please see the RAP Portal.

International Mentored Science Awardees

36 Awards

Award Recipient Award date Award Type
The Accuracy of Clinical TB Diagnoses among HIV positive and negative individuals in Zambia: Alternative Diagnoses, Treatment Outcomes, and Decision-Making Factors Mary Kagujje, MBChB, MSc Spring International Mentored Scientist Award
Assessment of chronic kidney disease and its progression among older people living with HIV in Uganda Judith Amutuhaire Ssemasaazi, MD Spring International Mentored Scientist Award
“For Us by Us:” A Peer-led Community-Informed Exploratory Study to Increase HIV-Self Testing and PrEP Uptake Among Men who have Sex with Men in Nairobi, Kenya Maureen Akolo, RN, PhD Spring International Mentored Scientist Award
Prevalence and outcomes associated with SARS-COV-2 antibody seropositivity among persons at risk for tuberculosis in a high HIV-burden setting: a cohort study in Lusaka, Zambia Nsala Sanjase, MBChB Spring International Mentored Scientist Award
Potential for Xpert MTB/RIF Ultra cycle threshold values to monitor early response to anti-TB treatment in HIV co-infected patients on antiretroviral therapy Juliet Namugenyi, MSc Spring International Mentored Scientist Award
Prevalence, clinical and immunological predictors of frailty among older adults with HIV in Kampala Phoebe Mbabazi, MD Fall International Mentored Scientist Award
Adaptation of a Mindfulness based intervention to support Adherence to Antiretroviral Therapy among adolescents in Uganda Khamisi Musanje, M.A. Fall International Mentored Scientist Award
Willingness and Feasibility of Using Injectable Antiretroviral Therapy among Women who Retained and Disengaged from Prevention of Mother to Child HIV Transmission Programs in Uganda Deborah Ekusai-Sebatta, PhD Spring International Mentored Scientist Award
Changes in insulin kinetics in HIV infected patients diagnosed with dolutegravir associated diabetes in Uganda Frank Mulindwa, MD Fall International Mentored Scientist Award
Impact Evaluation of a Primary Care Health System Strengthening Intervention on HIV and TB services in Kono and Kailahun Districts, Sierra Leone Mohamed Bailor Barrie, MD, PhD (Cand) Spring International Mentored Scientist Award
Evaluation of an African specific Donor Health Questionnaire for HIV screening in Cameroonian blood services Claude Tayou-Tagny MCR/MPH/MS, MD, MSC Fall International Mentored Scientist Award
Investigating into the social, health and economic vulnerabilities and resilience of children of women at high risk of HIV in Kampala Agnes Ssali, PhD Fall International Mentored Scientist Award
Effect of human immunodeficiency virus type 1 (HIV-1) subtype C transactivator of transcription (Tat) P21A variant on nuclear levels of active positive transcription elongation factor b (P-TEFb) and viral latency Paradise Madlala, PhD Fall International Mentored Scientist Award
Exploring HIV care of highly mobile HIV-positive youth living in Kenya and Uganda: qualitative study to identify gaps in the HIV care cascade and evaluate feasible intervention options Irene Maeri , BA, MA Spring International Mentored Scientist Award
Testing Medicinal Plants from Uganda for HIV Latency Reversing Activity Emmanuel Mande, Bsc Spring International Mentored Scientist Award
Understanding factors that facilitate effective uptake and integration of health interventions in South African primary health care clinics van Heerden Alastair, PhD Fall International Mentored Scientist Award
Patients and peer navigators lived experiences and drivers for creating a successful personalized adaptive care relationship to treat lapses HIV treatment retention: a longitudinal qualitative study Zachary Kwena, PhD(c), MA Fall International Mentored Scientist Award
Understanding the impact of an income generating agricultural intervention on sexual behaviour and psychological well being of adolescent girls and young women living in a high HIV urban setting in Western Kenya Mariacianah Onono, MD Spring International Mentored Scientist Award
Development and Validation of an HPLC-UV Multiplex Assay for Therapeutic Drug Monitoring of Antiretroviral Drugs in Uganda Allan Buzibye, Bsc Fall International Mentored Scientist Award
Global gene array, secretome analyses, and HIV infection analyses of foreskin epithelial cells upon exposure to cervicovaginal fluid from healthy vs. women with bacterial vaginosis Grace Turyasingura, BSc Spring International Mentored Scientist Award
ComHealth: Cost-effective mHealth strategy to improve long-term retention in HIV care for mother-baby pairs Thomas Odeny, MBChB, MPH Spring International Mentored Scientist Award
Evaluation of a point-of-care assay for the diagnosis of Trichomonas vaginalis in women at high risk for HIV infection Sheila Nabweyambo, BSc Fall International Mentored Scientist Award
Feasibility of Screening and Brief Intervention for Hazardous Alcohol use amongst HIV-infected Adults in Uganda: A Qualitative Study Stephen Asiimwe, MMed, MBChB Spring International Mentored Scientist Award
Impact of Neonatal Exposure to Malaria and HIV on the Frequency, Phenotype, and Function of __ T Cell Subsets at Birth Fredrick Lutwama, PhD, MDChb Spring International Mentored Scientist Award
Promoting Positive Caregiver-Child Interaction Between HIV-Affected Children and Their Caregivers with Depression in Kwa-Zulu Natal, South Africa Duncan Andrew, MA Spring International Mentored Scientist Award
Investigation of Pediatric HIV Disclosure in Kampala, Uganda Monica Etima, MBChB, MMed Spring International Mentored Scientist Award
Evaluation of the Dynamics and Immuno-Virology of Human Papillomavirus Infections among Fishermen in Kisumu, Kenya Raphael Ondondo, PhD Fall International Mentored Scientist Award
Development of a Combination HIV Prevention Intervention for Transgender Women in Peru Alfonso Silva-Santisteban, MD, MPH Fall International Mentored Scientist Award
Mechanisms of CD4 T-cell death among HIV-infected, HAART-treated African adults displaying poor CD4 T-cell reconstitution despite effective viral suppression Damalie Nakanjako, MBChB, MMed, PhD Fall International Mentored Scientist Award
A study to evaluate the acceptability and feasibility of providing integrated HIV and maternal and child health services thorough well child services in KwaZulu Natal, South Africa Christiane Horwood, MBBS Fall International Mentored Scientist Award
Adaptation of a Male Partner Educational Intervention Tool for Vaginal Microbicide Trials Serah Wagikondi-Gitome, MBChB Fall International Mentored Scientist Award
Optimizing Nevirapine Dosing in Patients Co-infected with Tuberculosis and HIV in Harare, Zimbabwe Luther Gwaza, PhD Spring International Mentored Scientist Award
Examining Sexual Concurrency and Sexual Networks among Married Fishermen Couples in Kisumu District, Kenya Zachary Kwena, PhD(c), MA Fall International Mentored Scientist Award
Family Planning Use Among Female Clients Attending The HIV/AIDS Clinic In Mbarara University Teaching Hospital Winnie Muyindike, MBChB, MMed, DPAM Spring International Mentored Scientist Award
Frequency and evolution of HIV-1 drug resistance among Ugandan children receiving antiretroviral therapy Jane Achan, MBChB, MMed, MSc Spring International Mentored Scientist Award
Perioperative Exposure to Blood and Body Fluids: Incidence, Causes and Attitudes in Uganda Timothy Kimuli, MBChB, MMed Spring International Mentored Scientist Award
Contacts
  • Global gene array, secretome analyses, and HIV infection analyses of foreskin epithelial cells upon exposure to cervicovaginal fluid from healthy vs. women with bacterial vaginosis

    Global gene array, secretome analyses, and HIV infection analyses of foreskin epithelial cells upon exposure to cervicovaginal fluid from healthy vs. women with bacterial vaginosis

    Abstract

    Bacterial vaginosis (BV), a disruption of the normal vaginal flora, has recently been associated with a greater than 3-fold increased risk of female-to-male HIV-1 transmission in a manner not accounted for by plasma HIV-1 RNA load(1). We hypothesize that compared to cervicovaginal fluid (CVF) from healthy individuals, BV CVF induces an elevated pro-inflammatory and pro-chemotactic response in cells of the foreskin which may facilitate transmission.

  • Evaluation of a point-of-care assay for the diagnosis of Trichomonas vaginalis in women at high risk for HIV infection

    Evaluation of a point-of-care assay for the diagnosis of Trichomonas vaginalis in women at high risk for HIV infection

    Abstract

    Trichomoniasis, caused by the protozoan parasite, Trichomonas vaginalis (TV), is the most common, curable sexually transmitted infection worldwide with a particularly high prevalence of up to 35% among women in Sub-Saharan Africa (SSA). This region of the world is also home to almost 70% of new human immunodeficiency virus (HIV) infections occurring worldwide and most of these infections occur in women. Recent studies showed that TV infection in African women is associated with a 1.5 ? 2.7-fold increased risk for HIV infection.

  • Perioperative Exposure to Blood and Body Fluids: Incidence, Causes and Attitudes in Uganda

    Perioperative Exposure to Blood and Body Fluids: Incidence, Causes and Attitudes in Uganda

    Abstract

    Protection of operating theatre personnel from bloodborne pathogens has been neglected in Uganda. Nature, frequency, risk factors, and preventive measures for perioperative exposure of theatre personnel will be identified by conducting a 6 month cross-sectional study in Mulago Hospital, Uganda. Multiple logistic regression will analyze risk factors for exposure. Case exposure rate and cumulative risk of seroconversion of HIV will be calculated. Surveys of theatre personnel will assess knowledge, attitude, and practice for risks of perioperative bloodborne infections.

  • Family Planning Use Among Female Clients Attending The HIV/AIDS Clinic In Mbarara University Teaching Hospital

    Family Planning Use Among Female Clients Attending The HIV/AIDS Clinic In Mbarara University Teaching Hospital

    Abstract

    The use of family planning has been shown to have strong potential to reduce new HIV infections due to unwanted fertility in Uganda. Most prevention of mother to child transmission PMTCT efforts to date have prioritized the provision of antiretroviral prophylaxis to HIV infected pregnant women, leaving voluntary contraception an underutilized approach despite evidence that preventing unintended pregnancies in the HIV infected women is an effective strategy for reducing HIV positive births and is cost effective.

  • Examining Sexual Concurrency and Sexual Networks among Married Fishermen Couples in Kisumu District, Kenya

    Examining Sexual Concurrency and Sexual Networks among Married Fishermen Couples in Kisumu District, Kenya

    Headshot of

    Abstract

    Determining the prevalence of sexual concurrent partnerships among married couples and the structure and characteristics of the resultant sexual networks is crucial in designing appropriate HIV prevention interventions. In this study we seek to: (a) identify the types and extent of concurrent sexual partnerships and, (b) elucidate the structure and characteristics of sexual networks that result from concurrent sexual partnerships among married fishermen couples in Kisumu, Kenya.

  • Optimizing Nevirapine Dosing in Patients Co-infected with Tuberculosis and HIV in Harare, Zimbabwe

    Optimizing Nevirapine Dosing in Patients Co-infected with Tuberculosis and HIV in Harare, Zimbabwe

    Headshot of

    Abstract

    Nevirapine (NVP) is the primary antiretroviral (ART) available in Zimbabwe. However, its use as first line ART is complicated by interactions with rifampicin (RIF), the primary drug available for tuberculosis (TB). In some cases ART treatment is delayed or avoided in TB co-infected patients. Previous studies of the effect of RIF on NVP pharmacokinetic (PK) exposure has been inconclusive, failing to generate specific recommendations regarding co-treatment. Moreover, PK and safety data for NVP with RIF have not been generated in our population in Zimbabwe.

  • A study to evaluate the acceptability and feasibility of providing integrated HIV and maternal and child health services thorough well child services in KwaZulu Natal, South Africa

    A study to evaluate the acceptability and feasibility of providing integrated HIV and maternal and child health services thorough well child services in KwaZulu Natal, South Africa

    Abstract

    In the KwaZulu-Natal (KZN) province of South Africa (SA), where antenatal HIV prevalence is 39.5%, there has been substantial impact of programs to prevent mother-to-child transmission (PMTCT) of HIV.However, despite the recognized benefits of early ART initiation for HIV-infected infants and maternal health care, there is substantial loss to follow-up of HIV-infected mothers and their infants after delivery. Barriers to effective utilization of postnatal HIV care and treatment services include logistical factors, competing demands, and psychological factors such as fear of stigmatization.

  • Development of a Combination HIV Prevention Intervention for Transgender Women in Peru

    Development of a Combination HIV Prevention Intervention for Transgender Women in Peru

    Headshot of

    Abstract

    Transgender women are the population most affected by the HIV/AIDS epidemic in Peru because of issues that occur at individual, interpersonal, socio-cultural, and structural levels, as our team has demonstrated in previous research. A combination, multilevel intervention approach is needed incorporating strategies in order to address internalized oppression, self-regulation abilities, and sexual self-knowledge, along with biomedical approaches to HIV prevention. This proposal aims to conduct a one year qualitative study leading to an NIH grant to develop such an intervention strategy.

  • Adaptation of a Male Partner Educational Intervention Tool for Vaginal Microbicide Trials

    Adaptation of a Male Partner Educational Intervention Tool for Vaginal Microbicide Trials

    Headshot of

    Abstract

    In Sub-Saharan Africa, high hypothetical acceptability of vaginal microbicide trials among women has often been dampened by low male partner support. Formative work recently carried out among women in Kisumu, Kenya indicate that despite a high willingness (80%) to participate in upcoming vaginal microbicide trials, more than a third of the interviewees either did not think their partners would support their trial participation or were unsure of his support.